76 related articles for article (PubMed ID: 9154279)
21. Effects of Latanoprost and Bimatoprost on the Expression of Molecules Relevant to Ocular Inflow and Outflow Pathways.
Li X; He F; Gabelt BT; Wang Y; Cai S; Cao J; Fan N; Kaufman PL; Liu X
PLoS One; 2016; 11(3):e0151644. PubMed ID: 27011234
[TBL] [Abstract][Full Text] [Related]
22. Ophthalmic drug delivery in glaucoma-a review.
Januleviciene I; Siaudvytyte L; Barsauskaite R
Pharmaceutics; 2012 Mar; 4(1):243-51. PubMed ID: 24300191
[TBL] [Abstract][Full Text] [Related]
23. Clinical options for the reduction of elevated intraocular pressure.
Crawley L; Zamir SM; Cordeiro MF; Guo L
Ophthalmol Eye Dis; 2012; 4():43-64. PubMed ID: 23650457
[TBL] [Abstract][Full Text] [Related]
24. Baseline Factors Predictive of SLT Response: A Prospective Study.
Bruen R; Lesk MR; Harasymowycz P
J Ophthalmol; 2012; 2012():642869. PubMed ID: 22900148
[TBL] [Abstract][Full Text] [Related]
25. Feline glaucoma--a comprehensive review.
McLellan GJ; Miller PE
Vet Ophthalmol; 2011 Sep; 14 Suppl 1(Suppl 1):15-29. PubMed ID: 21923820
[TBL] [Abstract][Full Text] [Related]
26. Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension.
Lee AJ; McCluskey P
Clin Ophthalmol; 2010 Jul; 4():741-64. PubMed ID: 20689791
[TBL] [Abstract][Full Text] [Related]
27. First-line treatment for elevated intraocular pressure (IOP) associated with open-angle glaucoma or ocular hypertension: focus on bimatoprost.
Law SK
Clin Ophthalmol; 2007 Sep; 1(3):225-32. PubMed ID: 19668476
[TBL] [Abstract][Full Text] [Related]
28. Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction.
Toris CB; Gabelt BT; Kaufman PL
Surv Ophthalmol; 2008 Nov; 53 Suppl1(SUPPL1):S107-20. PubMed ID: 19038618
[TBL] [Abstract][Full Text] [Related]
29. Aqueous humor dynamics associated with the phorbol ester-induced decrease in intraocular pressure in the rabbit.
Oka T; Taniguchi T; Kitazawa Y; Sagara T; Nishida T
Jpn J Ophthalmol; 2006; 50(6):497-503. PubMed ID: 17180522
[TBL] [Abstract][Full Text] [Related]
30. Relation between axial length of the eye and hypotensive effect of latanoprost in primary open angle glaucoma.
Arranz-Marquez E; Teus MA
Br J Ophthalmol; 2004 May; 88(5):635-7. PubMed ID: 15090414
[TBL] [Abstract][Full Text] [Related]
31. Latanoprost : an update of its use in glaucoma and ocular hypertension.
Perry CM; McGavin JK; Culy CR; Ibbotson T
Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
[TBL] [Abstract][Full Text] [Related]
32. The effect of latanoprost on aqueous humor PGF2alpha levels in glaucoma patients.
Güven D; Karakurt A; Saban E; Hasiripi H
Int Ophthalmol; 1999; 23(2):91-6. PubMed ID: 11196126
[TBL] [Abstract][Full Text] [Related]
33. A preliminary risk-benefit assessment of latanoprost and unoprostone in open-angle glaucoma and ocular hypertension.
Eisenberg DL; Camras CB
Drug Saf; 1999 Jun; 20(6):505-14. PubMed ID: 10392667
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandin A2 increases uveoscleral outflow and trabecular outflow facility in the cat.
Toris CB; Yablonski ME; Wang YL; Hayashi M
Exp Eye Res; 1995 Dec; 61(6):649-57. PubMed ID: 8846836
[TBL] [Abstract][Full Text] [Related]
35. Effect of topical prostaglandin D2 on the aqueous humor dynamics in rabbits.
Goh Y; Araie M; Nakajima M; Azuma I; Hayaishi O
Graefes Arch Clin Exp Ophthalmol; 1989; 227(5):476-81. PubMed ID: 2478423
[TBL] [Abstract][Full Text] [Related]
36. The effect of prostaglandin F2 alpha-1-isopropylester (PGF2 alpha-IE) on uveoscleral outflow.
Nilsson SF; Sperber GO; Bill A
Prog Clin Biol Res; 1989; 312():429-36. PubMed ID: 2678148
[TBL] [Abstract][Full Text] [Related]
37. The uveoscleral outflow routes.
Nilsson SF
Eye (Lond); 1997; 11 ( Pt 2)():149-54. PubMed ID: 9349404
[TBL] [Abstract][Full Text] [Related]
38. Initial clinical studies with prostaglandins and their analogues.
Camras CB; Alm A
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S61-8. PubMed ID: 9154278
[TBL] [Abstract][Full Text] [Related]
39. Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function.
Toris CB; Camras CB; Yablonski ME; Brubaker RF
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S69-75. PubMed ID: 9154279
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
